Publication | Closed Access
Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1<sup>st</sup>-line advanced gastric cancer patients
87
Citations
0
References
2005
Year
OncologyGastrointestinal OncologyGastrointestinal PharmacologyMedicineClinical TrialsGastroenterologyGastric Cancer PatientsVs CddpPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyCancer ResearchPhase 3Health Sciences
4003